ROHAN MATTHEWS: Open Payments
NPI 1265143721 · CHARLOTTE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,830 in 172 payments from 14 companies in 2025. Trend: 2023 $1,511 · 2024 $2,379 · 2025 $3,830
Food & beverage: $3,691Education: $139
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 16 | $612 |
| Otsuka America Pharmaceutical, Inc. | 23 | $470 |
| Vanda Pharmaceuticals Inc. | 21 | $445 |
| E.R. Squibb & Sons, L.L.C. | 20 | $364 |
| Janssen Pharmaceuticals, Inc | 8 | $287 |
| ABBVIE INC. | 17 | $286 |
| Axsome Therapeutics, Inc. | 9 | $280 |
| Alkermes, Inc. | 10 | $238 |
| Almatica Pharma LLC | 11 | $211 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $211 |
Products named: REXULTI, FANAPT, COBENFY, AUSTEDO XR, INVEGA SUSTENNA, VRAYLAR, Auvelity, LOREEV XR.
Industry payments across NC — which companies pay providers there.
